Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Osteoarthritis (OA), a debilitating joint disorder affecting millions worldwide, is characterized by persistent inflammation, oxidative stress, and irreversible cartilage breakdown, yet remains without disease-modifying therapies. Inspired by natural enzymatic cascades, we developed a bioinspired nanocomposite hydrogel, N,S-doped Mn-Nb (C-CeO), that mimics endogenous antioxidant pathways to reprogram the OA microenvironment. This system combines N,S-doped Mn-Nb2C MXene nanosheets with CeO2 nanozymes within a boronate ester-crosslinked hydrogel, forming an “immuno-redox circuitry” with four synergistic functions: (1) cascade reactive oxygen species (ROS) scavenging via superoxide dismutase-like Mn-Nb2C and catalase-like CeO2, amplified by photothermal enhancement under near-infrared irradiation; (2) broad reactive nitrogen species clearance, removing peroxynitrite (ONOO−), nitric oxide (NO), and nitroxyl (NO−) to mitigate inflammation; (3) immunomodulation through Mn2+-activated cGAS-STING signaling, which promoted macrophage polarization toward the M2 phenotype, concomitantly reducing the levels of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α); (4) cartilage regeneration via pH/ROS-responsive simvastatin (SIM) release and nanocatalysis, upregulating SRY-box transcription factor 9 (SOX9) and Col2a1 while inhibiting matrix metalloproteinase-13 (MMP-13) and a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5). In a murine OA model, the system reduced synovitis by 60%, restored 80% of cartilage thickness, and suppressed osteophyte formation, outperforming single-component treatments. This strategy pioneers a “self-healing cartilage” approach by integrating nanocatalysis with immunoengineering for transformative OA therapy.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).
Comments on this article